NPCE
Neuropace
$15.30
+$0.49 (+3.31%)Jul 27, 2026
Key metrics
The numbers that frame NPCE today
- Market cap
- $521.63M
- P/E (TTM)
- -24.2
- EV / FCF
- -58.6
- Gross margin
- 78.3%
- EV / Sales
- 5.8
- ROIC
- -10.7%
- Div yield
- 0%
- Debt / equity
- 4.9
- 52wk Low
- $7.56
- 52wk High
- $19.60
Growth
Revenue and earnings trend for NPCE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NPCE
Is Neuropace a good buy?
Yes. Neuropace has strong quality and excellent momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think Neuropace is selling at a high price, which cuts against the buy case.
What is the market capitalization of NPCE?
Neuropace's market capitalization is $521.63M.
What is the P/E ratio for NPCE stock?
Neuropace's current P/E ratio is -24.2.
What is the 52-week high for NPCE stock?
The 52-week high for Neuropace is $19.60. The current close of $15.30 is 21.9% below that high.
What is the 52-week low for NPCE stock?
The 52-week low for Neuropace is $7.56. The current close of $15.30 is 102.3% above that low.
Does NPCE stock pay dividends?
Neuropace does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NPCE?
Neuropace's Debt / Equity ratio is 4.88.